Skip links and keyboard navigation

    Media Statements

    Coat of ArmsMedia Release
    Premier and Minister for Trade
    The Honourable Annastacia Palaszczuk

    Queensland research helps deliver ground-breaking diagnosis technology

    Premier and Minister for Trade
    The Honourable Annastacia Palaszczuk

    Saturday, June 02, 2018

    Queensland research helps deliver ground-breaking diagnosis technology

    Medical conditions ranging from breast cancer to Post Traumatic Stress Disorder could be diagnosed much more quickly through research being done by Queensland researchers working with US artificial intelligence technology.

    As part of her trade mission to the United States, Premier Annastacia Palaszczuk saw the work being undertaken by the team from the Innovation and Translation Centre at Brisbane’s Translational Research Institute (TRI).

    “It’s through my Government’s Advance Queensland program that we’ve been able to support the TRI’s Innovation and Translation Centre, which allows the TRI to collaborate with Siemens Heathineers here at Draper Laboratories,” the Premier said.

    The team from TRI and Siemens Healthineers are using an extension of Magnetic Resonance Imaging (MRI) technology called magnetic resonance spectroscopy.

    MRS allows researchers to learn more about the chemical content of tissues and organs, providing a deeper understanding and earlier detection of conditions like PTSD.

    “TRI’s goal is to turn this research into a new medical technology to improve the diagnosis of conditions such as PTSD,” the Premier said.

    “For the first time, medical clinicians will be able to identify the changes in a patient’s brain chemistry associated with Post Traumatic Stress Disorder (PTSD) or blast injury.

    “MRS also offers the ability to assess women at high risk of breast cancer in whom very early tissue changes can be identified.

    “We hope this breakthrough will give a greater insight into these conditions and diseases, allowing for quicker diagnoses.

    “For example, with breast cancer, it is hoped the technology will detect the cellular changes leading to the disease years before the cancer emerges.”

    TRI CEO Professor Carolyn Mountford said the newly developed scanning technologies and techniques would provide a better platform for the diagnosis, monitoring and treatment of cancer, trauma, immunotherapy, chronic pain and other disorders and diseases.

    “This will be a game-changer, as we will soon have the technology available to us to have a non-invasive test for PTSD to determine if soldiers and emergency workers are prone to the disorder and if so, can be rested or not immediately deployed again,” Professor Mountford said.

    Media Contact:  Geoff Breusch 0417 272 875